Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Diabetes is a major predictor of death from heart disease and stroke; its impact on nonvascular mortality, including specific cancers, is less understood. We examined the association of diabetes with cause-specific mortality, including deaths from specific cancers. RESEARCH DESIGN AND METHODS: A prospective cohort of 1,053,831 U.S. adults, without cancer at baseline, enrolled in the Cancer Prevention Study-II in 1982 and was followed for mortality until December 2008. At baseline, participants completed a self-administered questionnaire that included information on diabetes, smoking, physical activity, height, and weight. Multivariable-adjusted relative risks (RRs) (95% CI) were estimated using Cox proportional hazards regression. RESULTS: During 26 years of follow-up, 243,051 men and 222,109 women died. In multivariable models that controlled for age, BMI, and other variables, diabetes was associated with higher risk of all-cause mortality (women RR 1.90 [95% CI 1.87–1.93]; men 1.73 [1.70–1.75]). Among women, diabetes was associated with higher risk of death from cancers of the liver (1.40 [1.05–1.86]), pancreas (1.31 [1.14–1.51]), endometrium (1.33 [1.08–1.65]), colon (1.18 [1.04–1.33]), and breast (1.16 [1.03–1.29]). Among men, diabetes was associated with risk of death from cancers of the breast (4.20 [2.20–8.04]), liver (2.26 [1.89–2.70]), oral cavity and pharynx (1.44 [1.07–1.94]), pancreas (1.40 [1.23–1.59]), bladder (1.22 [1.01–1.47]), colon (1.15 [1.03–1.29]), and (inversely) prostate (0.88 [0.79–0.97]). Diabetes was also associated with higher risks of death involving the circulatory system, respiratory system, digestive system, genitourinary system, and external causes/accidental deaths. CONCLUSIONS: Diabetes is associated with higher risk of death for many diseases, including several specific forms of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The main limitation of these studies is the wide variation in methodologies including differences in the type, formulation, concentration, and duration of exposure to probiotics.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1710]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Several RCTs and systematic reviews/meta-analyses have noted a positive effect of probiotics on glucose, A1C, lipids, and BP.1705–1714”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1710]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · cited 1×
“The global prevalence of adults with diabetes is projected to reach 366 million in 2030, more than double the estimated prevalence for 2000 (1).”
BackgroundJemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“BMI, a major risk factor for endometrial cancer incidence (35) and mortality (36).”
BackgroundRenehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219 · cited 1×
“BMI, a major risk factor for endometrial cancer incidence (35) and mortality (36).”
BackgroundThe Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125 · cited 2×
“Men and women with diabetes also experience about twofold higher risks of death from macrovascular disease, including heart disease and stroke (2,3).”
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366 · cited 2×
“Consistent with other prospective studies (6,18) and the conclusion from an expert report (8), we did not observe an association between diabetes and lung cancer mortality.”
BackgroundResultSelf-citationAssociation Between Smoking and Risk of Bladder Cancer Among Men and Women
Freedman, N. D. (2011) · JAMA · doi:10.1001/jama.2011.1142 · Cited by 1,141 · cited 1×
“Cigarette smoking is the primary risk factor for bladder cancer (31) and a weak risk factor for diabetes (32); thus, inclusion of smoking data in this study is a strength.”
BackgroundDiabetes and Cancer: A Consensus Report
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20078 · Cited by 1,055
Self-citationFasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 988 · cited 1×
“Only one of these other studies stratified associations by sex; there was a higher risk of bladder cancer mortality among men, but results among women were not presented (5).”
Research works printed but not linked: 2
- Centers for Disease Control and Prevention, 2011, National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011
- World Health Organization, 1985, International Classification for Diseases
Cited by
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Aune, D., Sen, A., Prasad, M., Norat, T., Janszky, I., Tonstad, S., Romundstad, P., & Vatten, L. J. (2016) · BMJ · doi:10.1136/bmj.i2156 · Cited by 953
Obesity and diabetes: the increased risk of cancer and cancer-related mortality
Gallagher, E. J., & LeRoith, D. (2015) · Physiological Reviews · doi:10.1152/physrev.00030.2014 · Cited by 806
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China
Bragg, F., Holmes, M. V., Iona, A., Guo, Y., Du, H., Chen, Y., Bian, Z., Yang, L., Herrington, W., Bennett, D., et al. (2017) · JAMA · doi:10.1001/jama.2016.19720 · Cited by 497
“In many Western populations, diabetes is associatedwithmore deaths from IHD than fromstroke,whereas in China the opposite is true, even though themortality RRs for IHD and stroke in the present study were similar to those reportedpreviously.(7-9)Moreover,existingevidencerelatinghemorrhagic stroke to diabetes ismore li…”
BackgroundResultGregg, E. W., Cheng, Y. J., Srinivasan, M., Lin, J., Geiss, L. S., Albright, A. L., & Imperatore, G. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30314-3 · Cited by 480
The InterAct Consortium (2015) · Diabetologia · doi:10.1007/s00125-015-3585-9 · Cited by 468
“The number of people living with diabetes (mostly type 2 diabetes) worldwide has been projected to increase from 366 million in 2011 to 552 million by 2030 [1], and this trend will have important public health implications in terms of morbidity [2], mortality [2, 3] and healthcare costs [4].”
BackgroundEpidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Hyperinsulinemia in Obesity, Inflammation, and Cancer
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 305
“Obesity and diabetes are risk factors for many different types of cancers [5,196-200].”
BackgroundEvaluating All Potential Oral Complications of Diabetes Mellitus
Verhulst, M. J. L., Loos, B. G., Gerdes, V. E. A., & Teeuw, W. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00056 · Cited by 276
Ambient Air Pollution and Cancer Mortality in the Cancer Prevention Study II
Turner, M. C., Krewski, D., Diver, W. R., Pope, C. A., Burnett, R. T., Jerrett, M., Marshall, J. D., & Gapstur, S. M. (2017) · Environmental Health Perspectives · doi:10.1289/ehp1249 · Cited by 274
“2015), have also been observed to be at increased risk for bladder, kidney, and colorectal cancers, although it is unclear whether this is due to shared underlying risk factors (such as obesity) or to other metabolic features of the disease (such as hyperinsulinemia, hyperglycemia, or chronic inflammation) (Campbell e…”
BackgroundSelf-citationCurrent efforts and trends in the treatment of NASH
Ratziu, V., Goodman, Z., & Sanyal, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.041 · Cited by 262
Nathan, D. M., Buse, J. B., Kahn, S. E., Krause-Steinrauf, H., Larkin, M. E., Staten, M., Wexler, D., Lachin, J. M., & the GRADE Study Research Group (2013) · Diabetes Care · doi:10.2337/dc13-0356 · Cited by 254
“Cardiovascular disease (CVD) is increased by two- to fivefold in diabetes and is the leading cause of death (3).”
BackgroundType 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy
Shlomai, G., Neel, B., LeRoith, D., & Gallagher, E. J. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.4044 · Cited by 236
Obesity and cancer pathogenesis
Berger, N. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12416 · Cited by 231
Diabetes, Obesity, and Breast Cancer
Kang, C., LeRoith, D., & Gallagher, E. J. (2018) · Endocrinology · doi:10.1210/en.2018-00574 · Cited by 222
Aune, D. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz042 · Cited by 209
Wang, Y., O’Neil, A., Jiao, Y., Wang, L., Huang, J., Lan, Y., Zhu, Y., & Yu, C. (2019) · BMC Medicine · doi:10.1186/s12916-019-1355-0 · Cited by 207
Chen, Y., Wu, F., Saito, E., Lin, Y., Song, M., Luu, H. N., Gupta, P. C., Sawada, N., Tamakoshi, A., Shu, X.-O., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4229-z · Cited by 206
“The association with mortality from oesophageal cancer and stomach cancer in whites and Asians has been generally null [26, 27, 42], except for a South Korean study, which found a positive association between diabetes and the risk of death from both cancers in men [28].”
BackgroundResultInfluentialOhkuma, T., Peters, S. A. E., & Woodward, M. (2018) · Diabetologia · doi:10.1007/s00125-018-4664-5 · Cited by 188
Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies
Batabyal, P., Vander Hoorn, S., Christophi, C., & Nikfarjam, M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3625-6 · Cited by 183
Yang, J. J., Yu, D., Wen, W., Saito, E., Rahman, S., Shu, X.-O., Chen, Y., Gupta, P. C., Gu, D., Tsugane, S., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.2696 · Cited by 177
Mortality From Chronic Liver Diseases in Diabetes
Zoppini, G., Fedeli, U., Gennaro, N., Saugo, M., Targher, G., & Bonora, E. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.132 · Cited by 172
de Vos, A. F., Klaren, V. N. A., & Kijlstra, A. (1994) · PubMed · Cited by 180
The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms
Zhu, B., & Qu, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.800995 · Cited by 165
“It is worth noting that numerous studies that were conducted in Americans and Europeans indicated a reduced risk of prostate cancer in patients with T2DM (29, 30).”
BackgroundBody Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults
Campbell, P. T., Newton, C. C., Freedman, N. D., Koshiol, J., Alavanja, M. C., Beane Freeman, L. E., Buring, J. E., Chan, A. T., Chong, D. Q., Datta, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0787 · Cited by 149
Self-citationLiao, C., Zhang, D., Mungo, C., Andrew Tompkins, D., & Zeidan, A. M. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.095 · Cited by 162
Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study
Reimondo, G., Castellano, E., Grosso, M., Priotto, R., Puglisi, S., Pia, A., Pellegrino, M., Borretta, G., & Terzolo, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz284 · Cited by 149
Gallagher, E. J., & LeRoith, D. (2013) · Diabetes Care · doi:10.2337/dcs13-2001 · Cited by 145
“The 26-year follow-up data from the CPS II study have recently been published (15).”
BackgroundInfluentialHalvorsen, R. E., Elvestad, M., Molin, M., & Aune, D. (2021) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2020-000218 · Cited by 157
Bonnefond, A., Skrobek, B., Lobbens, S., Eury, E., Thuillier, D., Cauchi, S., Lantieri, O., Balkau, B., Riboli, E., Marre, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2700 · Cited by 139
Survival of Patients with Stage IV Lung Cancer with Diabetes Treated with Metformin
Lin, J. J., Gallagher, E. J., Sigel, K., Mhango, G., Galsky, M. D., Smith, C. B., LeRoith, D., & Wisnivesky, J. P. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1395oc · Cited by 137
“Patients with diabetes are at higher risk for developing cancer, including breast, colorectal, pancreatic and lung malignancies (6-9).”
Habib, S. L., & Rojna, M. (2013) · ISRN Oncology · doi:10.1155/2013/583786 · Cited by 140
Ran, H., Zhu, Y., Deng, R., Zhang, Q., Liu, X., Feng, M., Zhong, J., Lin, S., Tong, X., & Su, Q. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0711-9 · Cited by 139
Insulin Resistance: The Increased Risk of Cancers
Szablewski, L. (2024) · Current Oncology · doi:10.3390/curroncol31020075 · Cited by 134
“In one study, a significantly increased age-adjusted risk of death [247] was reported.”
BackgroundLeti, F., Legendre, C., Still, C. D., Chu, X., Petrick, A. T., Gerhard, G. S., & DiStefano, J. K. (2017) · Translational research · doi:10.1016/j.trsl.2017.09.001 · Cited by 125
Chettouh, H., Lequoy, M., Fartoux, L., Vigouroux, C., & Desbois‐Mouthon, C. (2015) · Liver International · doi:10.1111/liv.12903 · Cited by 146
O’Brien, M. J., Karam, S. L., Wallia, A., Kang, R. H., Cooper, A. J., Lancki, N., Moran, M. R., Liss, D. T., Prospect, T. A., & Ackermann, R. T. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6125 · Cited by 113
Aune, D., & VATTEN, L. J. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.11.012 · Cited by 127
Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future
Davidson, M. A., Mattison, D. R., Azoulay, L., & Krewski, D. (2018) · Critical Reviews in Toxicology · doi:10.1080/10408444.2017.1351420 · Cited by 112
“…cancers, as well as increased cancer mortality from all combined cancers in several studies (Vigneri 2009; Giovannucci et al. 2010; Nicolucci 2010; Renehan et al. 2010; Bosetti et al. 2012; Campbell et al. 2012; Gallagher and LeRoith 2013; also refer to Supplementary Appendix 4 and Table S4).”
BackgroundAune, D., Schlesinger, S., Norat, T., & Ríboli, E. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.02.011 · Cited by 117
Atkin, M., Laight, D. W., & Cummings, M. H. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.003 · Cited by 124
“9%) cited by Chowienczyk et al. (1999) rather than the diabetes group (11.”
BackgroundAdult Stem Cells and Diseases of Aging
Boyette, L., & Tuan, R. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3010088 · Cited by 108
“Despite the occurrence of insulin resistance and other attempts by cells to thwart oncogenic transformation in an aging metabolic system, metabolic disease is frequently associated with a higher incidence of cancers [140], particularly in sites with a high degree of cell metabolism and/or turnover.”
BackgroundWang, B., An, X., Shi, X., & Zhang, J.-A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0952 · Cited by 100
Diabetes and Cancer—An AACE/ACE Consensus Statement
Handelsman, Y., LeRoith, D., Bloomgarden, Z. T., Dagogo-Jack, S. E., EINHORN, D. F., Garber, A. J., Grunberger, G., Harrell, R. M., Gagel, R. F., Lebovitz, H. E., et al. (2013) · Endocrine Practice · doi:10.4158/ep13248.cs · Cited by 105
“…Oropharyngeal RR 1.44a 1.07-1.94 Pancreatic RR 1.40a 1.23-1.59 Bladder RR 1.22a 1.01-1.47 Colon RR 1.15a 1.03-1.29 Prostate RR 0.88a 0.79-0.97 Campbell et al 2012 (women) (65) Hepatic RR 1.40a 1.05-1.86 Endometrial RR 1.33a 1.08-1.65 Pancreatic RR 1.31a 1.14-1.51 Colon RR 1.18a 1.04-1.33…”
BackgroundInfluentialInsulin resistance in patients with cancer: a systematic review and meta-analysis
Màrmol, J. M., Carlsson, M., Raun, S. H., Grand, M. K., Sørensen, J., Lehrskov, L. L., Richter, E. A., Norgaard, O., & Sylow, L. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2197124 · Cited by 104
Gong, Y., Wei, B.-J., Li, Y., & Pan, W. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.01.003 · Cited by 103
Nagle, C. M., Crosbie, E. J., Brand, A. H., Obermair, A., Oehler, M. K., Quinn, M. A., Leung, Y. C., Spurdle, A. B., & Webb, P. M. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.04.006 · Cited by 93
Cifarelli, V., Lashinger, L. M., Devlin, K. L., Dunlap, S. M., Huang, J. C., Kaaks, R., Pollak, M., & Hursting, S. D. (2015) · Diabetes · doi:10.2337/db14-1132 · Cited by 92
“3% of the population) and is associated with obesity and increased risk of developing and dying from cancer (1).”
BackgroundMethodJoung, K. H., Jeong, J., & Ku, B. J. (2015) · BioMed Research International · doi:10.1155/2015/920618 · Cited by 98
Type 2 Diabetes and 10-Year Risk of Dementia and Cognitive Impairment Among Older Mexican Americans
Mayeda, E. R., Haan, M. N., Kanaya, A. M., Yaffe, K., & Neuhaus, J. (2013) · Diabetes Care · doi:10.2337/dc12-2158 · Cited by 79
“Mortality associated with diabetes is slightly higher in our population than in two recent nationally representative studies: the National Health Interview Survey (20) and the Cancer Prevention Study-II (21).”
ResultCardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies
Wohlfart, P., Linz, W., Hübschle, T., Linz, D., Huber, J., Hess, S., Crowther, D., Werner, U., & Ruetten, H. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-84 · Cited by 78
Sharma, A., Green, J. B., Dunning, A., Lokhnygina, Y., Al-Khatib, S. M., Lopes, R. D., Buse, J. B., Lachin, J. M., Van de Werf, F., Armstrong, P. W., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1091 · Cited by 80
Diabetes, use of antidiabetic drugs, and the risk of glioma
Seliger, C., Ricci, C., Meier, C. R., Bodmer, M., Jick, S. S., Bogdahn, U., Hau, P., & Leitzmann, M. F. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov100 · Cited by 82
Aune, D., Schlesinger, S., Mahamat‐Saleh, Y., Zheng, B., Udeh‐Momoh, C. T., & Middleton, L. T. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-00970-0 · Cited by 83
Cantiello, F., Cicione, A. M., Salonia, A., Riccardo Autorino, B., Nunzio, C. D., Briganti, A., Gandaglia, G., Dell’Oglio, P., Capogrosso, P., & Damiano, R. (2014) · International Journal of Urology · doi:10.1111/iju.12644 · Cited by 74
Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?
Scalera, A., & Tarantino, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9217 · Cited by 76
Gerhard, G. S., Legendre, C., Still, C. D., Chu, X., Petrick, A., & DiStefano, J. K. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00122 · Cited by 70
“Lipotoxicity, oxidative stress, cytokines, and other inflammatory molecules have been implicated in the molecular mechanisms leading to the progression of inflammation to fibrosis in NAFLD/NASH in the setting of risk factors such as obesity [8] and T2D [9, 10].”
BackgroundInfluentialKim, Y., Ejaz, A. M., Tayal, A., Spolverato, G., Bridges, J. F. P., Anders, R. A., & Pawlik, T. M. (2014) · Cancer · doi:10.1002/cncr.28843 · Cited by 68
Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System
Shao, S., Gill, A. A., Zahm, S. H., Jatoi, I., Shriver, C. D., McGlynn, K. A., & Zhu, K. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0439 · Cited by 68
“adults reported a 2-fold increased risk of all-cause mortality and a 16% increased risk of breast cancer– specific mortality among persons with diabetes (10).”
BackgroundGallagher, E. J., Alikhani, N., Tobin‐Hess, A., Blank, J., Buffin, N. J., Zelenko, Z., Tennagels, N., Ulrich, W., & LeRoith, D. (2013) · Diabetes · doi:10.2337/db13-0249 · Cited by 68
Gu, J., Yan, S., Wang, B., Shen, F., Cao, H., Fan, J., & Wang, Y. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2671 · Cited by 62
“In addition, inconsistent results were reported regarding the strength of this association when stratifying for sex: several studies reported higher risk for men with type 2 DM [11,15,21,24] and others for women with type 2 DM [12,16–18,27,28].”
ResultHanson, A., Wilhelmsen, D., & DiStefano, J. K. (2018) · Non-Coding RNA · doi:10.3390/ncrna4030018 · Cited by 60
“While oxidative stress [21], pro-inflammatory cytokines [22,23], and immune response [24,25] have been associated with the coincident development of inflammation and fibrosis in NAFLD patients, the most common modifiable risk factors are obesity [26], dyslipidemia [27], and insulin resistance/T2D [28,29].”
BackgroundEmerging Roles of Cadmium and Heme Oxygenase in Type-2 Diabetes and Cancer Susceptibility
Satarug, S., & Moore, M. R. (2012) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.228.267 · Cited by 63
“In the USA, environmental exposures resulted in urinary cadmium ≥ 1 µg/g creatinine in 4.8% of non-smokers and 20.8% of smokers, although the population mean urinary cadmium was below 0.5 µg/g creatinine (Mortensen et al. 2011).”
BackgroundInfluentialZelenko, Z., & Gallagher, E. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.008 · Cited by 55
Associations between Diabetes Mellitus and Selected Cancers
Pliszka, M., & Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137476 · Cited by 61
“Another a prospective study showed a multivariable-adjusted RR = 1.33 (95% CI = 1.08–1.95) and an age-adjusted RR = 1.72 (95% CI = 1.40–2.12) [ 81].”
BackgroundInfluentialAune, D., Schlesinger, S., Norat, T., & Ríboli, E. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.09.009 · Cited by 56
Montemurro, N., Perrini, P., & Rapone, B. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228501 · Cited by 63
Diabetes Risk Reduction Diet and Survival after Breast Cancer Diagnosis
Wang, T., Farvid, M. S., Kang, J. H., Holmes, M. D., ROSNER, B. A., Tamimi, R. M., Willett, W. C., & Eliassen, A. H. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0256 · Cited by 56
Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
Gallagher, E. J., & LeRoith, D. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000433065.16918.83 · Cited by 53
Wang, Y., Huang, W., O'Neil, A. E., Lan, Y., Aune, D., Wang, W., Yu, C., & Chen, X. (2020) · Diabetologia · doi:10.1007/s00125-020-05214-4 · Cited by 55
Cao, J., Yan, W., Ma, X., Huang, H., & Yan, H. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab391 · Cited by 49
“25 times that of the general population (1, 2, 7, 89).”
Sugar- and Artificially-Sweetened Beverages and Cancer Mortality in a Large U.S. Prospective Cohort
McCullough, M. L., Hodge, R. A., Campbell, P. T., Guinter, M. A., & Patel, A. V. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0392 · Cited by 51
Self-citationReview article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis
Noureddin, M., Anstee, Q. M., & Loomba, R. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13620 · Cited by 51
Kiderlen, M., de Glas, N. A., Bastiaannet, E., Engels, C. C., van de Water, W., de Craen, A. J. M., Portielje, J. E. A., van de Velde, C. J. �., & Liefers, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt367 · Cited by 48
Diabetes mellitus and the risk of glioma: a meta-analysis
Zhao, L., Zheng, Z., & Huang, P. (2015) · Oncotarget · doi:10.18632/oncotarget.6605 · Cited by 48
Linking type 2 diabetes and gynecological cancer: an introductory overview
Anastasi, E., Filardi, T., Tartaglione, S., Lenzi, A., Angeloni, A., & Morano, S. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0982 · Cited by 53
Durrani, I. A., Bhatti, A., & John, P. C. L. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02040-5 · Cited by 49
“S adults revealed a 16% increase in breast cancer mortality in patients with preexisting diabetes [60].”
BackgroundGordon-Dseagu, V., Shelton, N. J., & Mindell, J. S. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.06.016 · Cited by 46
“75) for men.(36) Koskinen found a substantial increase in mortality among diabetic women (SMR 3.”
BackgroundMortality trends in patients with diabetes in Taiwan: A nationwide survey in 2000–2009
Li, H., Jiang, Y., Chang, C., Chung, C., Lin, B. J., & Chuang, L. (2012) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2012.09.013 · Cited by 46
Perez-Lopez, F. R., Pasupuleti, V., Gianuzzi, X., Palma-Ardiles, G., Hernandez-Fernandez, W., & Hernandez, A. V. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.04.001 · Cited by 45
Barami, K., Lyon, L. L., & Conell, C. A. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.06.164 · Cited by 48
Alternative RNA Splicing in the Pathogenesis of Liver Disease
Webster, N. J. G. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00133 · Cited by 44
Tocotrienol and Its Role in Chronic Diseases
Chin, K., Pang, K.-L., & Soelaiman, I. N. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41334-1_5 · Cited by 44
Chen, L., Chubak, J., Boudreau, D. M., Barlow, W. E., Weiss, N. S., & Li, C. I. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0687 · Cited by 44
Lee, S., Zhou, J., Guo, C. L., Wong, W. T., Liu, T., Wong, I. C. K., Jeevaratnam, K., Zhang, Q., & Tse, G. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.240 · Cited by 44
“2,3 Given the potentially lethal and debilitating nature of such cardiovascular adverse outcomes, many risk scores have been developed in hopes of identifying high-risk patients for early intervention and close monitoring.”
Targeting SHP2 as a therapeutic strategy for inflammatory diseases
Liu, Y., Yang, X., Wang, Y., Yang, Y., Sun, D., Li, H., & Chen, L. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113264 · Cited by 41
Goldstein, M. R., & Mascitelli, L. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0368-x · Cited by 42
Associations of Coffee Drinking and Cancer Mortality in the Cancer Prevention Study-II
Gapstur, S. M., Anderson, R. L., Campbell, P. T., Jacobs, E. J., Hartman, T. J., Hildebrand, J. S., Wang, Y., & McCullough, M. L. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0353 · Cited by 40
“There is also evidence that coffee consumption is associated with lower risk of insulin resistance (28) and type II diabetes (29), which have been associated with higher risks of colorectal, liver, breast and endometrial cancer incidence and/or mortality (30, 31).”
BackgroundSelf-citationFang, H., Shan, S., Zhou, Y., & Zhong, L. (2018) · BMC Cancer · doi:10.1186/s12885-018-4351-4 · Cited by 41
“Fourteen cohorts were conducted in Europe [21, 22, 25, 26, 39, 47, 48, 57–60, 63, 65, 73], 15 in Asia [23, 24, 40–44, 50, 53–55, 61, 64, 67–72, 74], and 9 in the US or Canada [19, 20, 45, 46, 49, 51, 52, 56, 62, 66].”
Novel cancer therapies and their association with diabetes
Shariff, A. I., Syed, S. H., Shelby, R. A., Force, J. M., Clarke, J. M., D’Alessio, D. A., & Corsino, L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0002 · Cited by 43
Liao, N., Zheng, Y., Xie, H., Zhao, B., Zeng, Y., Liu, X., & Liu, J. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0743-7 · Cited by 42
“Indeed, T2D significantly increases the risk of the entire spectrum of chronic liver diseases, including non-alcoholic liver disease, cirrhosis, and hepatocellular carcinoma [7–9], and the risk of death from chronic liver diseases is increased in patients with T2D [8, 10, 11].”
Adrenocortical tumors and insulin resistance: What is the first step?
Altieri, B., Tirabassi, G., Casa, S. D., Ronchi, C. L., Balercia, G., Orio, F., Pontecorvi, A., Colao, A., & Muscogiuri, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29950 · Cited by 40
Li, P., Fan, C., Cai, Y., Fang, S., Zeng, Y., Zhang, Y., Lin, X., Zhang, H., Xue, Y., & Guan, M. (2020) · Adipocyte · doi:10.1080/21623945.2020.1721970 · Cited by 39
Shin, J.-I., Sang, Y., Chang, A. R., Dunning, S. C., Coresh, J., Inker, L. A., Selvin, E., Ballew, S. H., & Grams, M. E. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019101119 · Cited by 38
“, baseline comparison periods: [1] August 7, 2012 to May 1, 2013; [2] May 2, 2013 to January 24, 2014; [3] January 25, 2014 to October 19, 2014; and [4] October 20, 2014 to July 14, 2015) to compare with the 9-month period prevalent cohort after the label change, and then, we assessed racial and sex differences in met…”
MethodKitahara, C. M., Linet, M. S., Brenner, A. V., Wang, S., Melin, B. S., Wang, Z., Inskip, P. D., Freeman, L. E. B., Braganza, M. Z., Carreón, T., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0913 · Cited by 40
He, Y., Tao, Q., Zhou, F., Si, Y.-X., Fu, R., Xu, B., Xu, J., Li, X., & Chen, B. (2021) · BMC Cancer · doi:10.1186/s12885-021-08854-w · Cited by 43
Yeap, B. B., McCaul, K. A., Flicker, L. A., Hankey, G. J., Almeida, O. P., Golledge, J., & Norman, P. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3339 · Cited by 39
Metadata
- Authors
- Campbell, P. T., Newton, C. C., Patel, A. V., Jacobs, E. J., & Gapstur, S. M.
- Affiliations
- American Cancer Society (US)
- Corresponding author
- Campbell, Peter T.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-08-14
- Volume
- 35
- Issue
- 9
- Pages
- 1835-1844
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3425000
- OpenAlex
- W1974792145
- Cited by
- 339
- References
- 41
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 26 · 2023: 16 · 2022: 27 · 2021: 31 · 2020: 33 · 2019: 13 · 2018: 35 · 2017: 27 · 2016: 26 · 2015: 25 · 2014: 22 · 2013: 23 · 2012: 8
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- diabetes mellitus, cause-specific mortality, cancer mortality, all-cause mortality, liver cancer, pancreatic cancer, breast cancer, colon cancer, endometrial cancer, bladder cancer, oral cavity and pharynx cancer, cardiovascular mortality, sex differences, Cancer Prevention Study II, prospective cohort, smoking, physical activity, body mass index
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Diabetes Mellitus, Humans, Middle Aged, Neoplasms, Prospective Studies, Surveys and Questionnaires, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.